These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 18053998

  • 1. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA, Reape KZ, Wininger S, Hait H.
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 3. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M, Kaunitz AM, Reape KZ, Hait H, Shu H.
    Menopause; 2009 Mar; 16(4):735-41. PubMed ID: 19252451
    [Abstract] [Full Text] [Related]

  • 4. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Mar; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 5. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
    Bachmann G, Bobula J, Mirkin S.
    Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
    [Abstract] [Full Text] [Related]

  • 6. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A.
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of vaginal administration of conjugated estrogens tablet on sexual function in postmenopausal women with sexual dysfunction: a double-blind, randomized, placebo-controlled trial.
    Bumphenkiatikul T, Panyakhamlerd K, Chatsuwan T, Ariyasriwatana C, Suwan A, Taweepolcharoen C, Taechakraichana N.
    BMC Womens Health; 2020 Aug 12; 20(1):173. PubMed ID: 32787848
    [Abstract] [Full Text] [Related]

  • 11. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA, Stevens RE, Ayres SA, Phelps KV.
    Climacteric; 2001 Mar 12; 4(1):19-27. PubMed ID: 11379374
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N.
    Clin Pharmacol Ther; 1998 Aug 12; 64(2):204-10. PubMed ID: 9728901
    [Abstract] [Full Text] [Related]

  • 14. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Aug 12; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 15. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
    Gast MJ, Freedman MA, Vieweg AJ, De Melo NR, Girão MJ, Zinaman MJ, Dyspareunia Study Group.
    Menopause; 2009 Aug 12; 16(2):247-56. PubMed ID: 19034054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.
    Portman DJ, Bachmann GA, Simon JA, Ospemifene Study Group.
    Menopause; 2013 Jun 12; 20(6):623-30. PubMed ID: 23361170
    [Abstract] [Full Text] [Related]

  • 20. Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens.
    Utian WH, Lederman SA, Williams BM, Vega RY, Koltun WD, Leonard TW.
    Obstet Gynecol; 2004 Feb 12; 103(2):245-53. PubMed ID: 14754691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.